Concepedia

Deena M. Maurer

DM

Statistics

Publications

9

Citations

585

H-Index

9

Active since

2000

Affiliations

UPMC Hillman Cancer Center(Current)

University of Pittsburgh

Parker Institute for Cancer Immunotherapy

The University of Texas MD Anderson Cancer Center

University of California, San Francisco

Deena M. Maurer is an author at UPMC Hillman Cancer Center specializing in oncology, cancer immunotherapy, and cancer immunology.

Publications per year

2000–2024

9

Publications

9

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 350 citations · Full text

, , +15

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

Walter J. Storkus, Deena M. Maurer, Yan Lin et al. · Journal for ImmunoTherapy of Cancer · 2021 · 55 citations · Full text

, , +17

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma

Lisa H. Butterfield, Lazar Vujanović, P.M.L. Santos et al. · Journal for ImmunoTherapy of Cancer · 2019 · 46 citations · Full text

, , +17

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients

Juraj Adamik, Paul V. Munson, Deena M. Maurer et al. · Nature Communications · 2023 · 34 citations · Full text

, , +16

Dysregulated NF-κB–Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma

Deena M. Maurer, Juraj Adamik, P.M.L. Santos et al. · Cancer Immunology Research · 2020 · 28 citations · Full text

, , +17

1–5 of 9